Power Law company profile

Liquidia Technologies

Biotech & Life Sciences · Morrisville, United States · Founded 2004 · IPO 2018 Unicorn

Development and commercialization of human therapeutics

Valuation

$3.49B

Market cap · May/2026

Revenue

$158M

Latest reported FY

EBITDA

$364M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

8 investors on Liquidia Technologies's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Wakefield Group LLC

Firelake Capital Management

Jenny Rooke

N47

Series B+ 4 investors entered at this stage

Canaan

Caligan Partners

North Carolina State University

NEA

Global footprint

Where Liquidia Technologies has talent and traffic

Workforce by country

🇺🇸 United States · Morrisville HQ

Book a demo for the full country breakdown

Web traffic by country

15K monthly visits
across markets

🇺🇸 United States48.7%

🇨🇦 Canada26%

🇬🇧 United Kingdom14%

🇮🇳 India7.3%

🇪🇸 Spain0.7%

Top 5 markets shown

Market sentiment

What the market is saying about Liquidia Technologies

An AI-synthesized read of the highest-engagement posts about Liquidia Technologies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Liquidia Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles